Assignment Prompt & Instructions
– 2 years ago
**files (2)**
– ## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx
– ## RoleDevelopmentinFamilyPracticeRDS.ST1.docx
**## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx**
**This is the second part and professor feedback of first part**
**Feedback** Good discussion make sure to use an appropriate tool on week 12 when evaluating the outcomes, specially using telemedicine
**Chosen Evidence-Based Technology Use in Disease or Risk Factor**
-Describe and summarize the evidence-based technology identified that has been shown to improve the condition or Risk Factor for your patient population chosen.
-Compare and contrast the positives and negatives of using this technology use chosen.
**Conclusion**
-Recap points discussed in the paper
-Importance of advancements in technology
**Signature Assignment. Submit the complete paper including the conclusion**
Completion requirements
**Opened:** Monday, March 24, 2025, 11:00 AM
**Due:** Sunday, March 30, 2025, 11:00 PM
Full description of the assignment is included at the end of the syllabus.
In this section the students needs to submit a complete assignment. Which includes: Introduction, Body and Conclusion.
Introduction:
**Introduction:**
Brief overview of the health of the population chosen
-Introduce the global burden of disease OR risk factor chosen
-Importance of improving the condition and its impact on quality of life
**Body of the Paper**
**Global Burden of Disease Condition/Risk Factor**
-Describe the disease OR risk factor chosen
-What signs/symptoms are identified in the patient that can be found?
-How is it diagnosed and treated?
**Technology and Healthcare**
-Describe the paradigm shift in healthcare related to technology
-Elaborate how technology can improve health outcomes in your population
**## RoleDevelopmentinFamilyPracticeRDS.ST1.docx**
1
**Role Development in Family Practice: Clinical Integration**
Student’s name
Name of institution
Course name and number
Instructor’s name
Due date
**Role Development in Family Practice: Clinical Integration**
Neonatal illness is an area of continued concern in international pediatrics, with numerous conditions causing rising rates of morbidity and mortality. One of these is neonatal respiratory distress syndrome, an incredibly debilitating illness in preterm neonates due to decreased production of surfactants. This illness results in acute breathing difficulty that, in most instances, warrants immediate specialized attention. RDS has an immense worldwide burden, most especially in developing nations where advanced neonatology facilities are not readily accessible According to World Health Organization reports, preterm birth complications, including RDS, contribute to nearly 35% of global neonatal deaths among the 2.5 million deaths documented in the year 2021. Additionally, the condition RDS occurs in about 1% of all live births, along with affecting 55% of preterm infants born at less than thirty-six weeks. Improved neonatal management and better neonatal diagnosis can significantly reduce neonatal mortality and subsequent complication rates, such as chronic pulmonary disease. The application of evidenced-based technologies in the form of point-of-care ultrasound and telemedicine is an opportunity to diagnose neonates better early in life to direct therapy and provide specialized therapy to remote populations. Applying these technologies is necessary to provide better outcomes for neonates with limited facilities in neonatal intensive units. Healthcare providers can accomplish this by providing timely interventions in neonates with these conditions through these technologies to avoid subsequent complications while improving the family's overall quality of life.
**Neonatal Respiratory Distress Syndrome**
Neonatal respiratory distress syndrome exists as a widespread, serious issue that affects premature infants born earlier than 38 weeks of gestational age. It comes from a deficiency of pulmonary surfactant that produces the condition, which results in high alveolar surface tension and prevents alveolar capacity to exchange gases. An undeveloped amount of surfactant during lung expansion can cause hypoxia, which afterward triggers respiratory failure in newborns. The condition also shows its initial symptoms when the newborn is between zero to a few hours old (Ying et al., 2021). The clinical features include rapid breathing, also known as tachypnea, combined with nasal flaring and grunting, chest retractions, and blue-colored skin, indicating hypoxia. Medical staff primarily make diagnoses of this condition based on clinical evidence alongside blood gas testing and chest X-ray imaging for detecting a distinctive pattern, and continuous positive airway pressure combined with ventilator support receives priority in treatments along with surfactant replacement therapy for promoting lung function.
**Technology and Healthcare**
Technology role has increased neonatal survival rates and reduced related morbidities in diseases like RDS in neonates. Advances in point-of-care ultrasound and telemedicine have provided neonatologists with additional capabilities to treat patients better in remote areas where neonatologists have limited accessibility (Padovani et al., 2023). Telemedicine has introduced remote evaluation, diagnosis, and management of neonates by healthcare providers, irrespective of physical location. It is particularly beneficial in areas where neonatologists and respiratory therapists have limited accessibility. Similarly, POCUS provides in-bed scanning to obtain instant, accurate results regarding pathologies in the lungs in the absence of radiographic exposure. All these tools accelerate early identification and management to achieve better outcomes in neonates and reduce mortality rates.
**Chosen Evidence-Based Technology**
The outcomes of neonatal RDS can be improved significantly by applying telemedicine in resource-limited settings. Neonatologists can support healthcare providers in rural or underserved units through live video conferencing to manage RDS appropriately and promptly. Telemedicine allows remote observation of neonates who have been ventilated to monitor outcomes and prevent unnecessary neonatal transfers while optimizing management programs to prevent complication rates. Telemedicine has been applied in neonatology with notable outcomes. Research has confirmed that telemedicine reduces unnecessary neonatal transfers by allowing remote specialist visits to prevent healthcare expenditures while improving specialist accessibility (Chuo et al., 2022). Telemedicine has been employed to empower parents through improved education to detect early symptoms of respiratory distress and initiate appropriate management in time. However, telemedicine is not free of certain limitations. Low penetration of the internet in specific locations can negate its potential. Additionally, regulatory and legal impediments to the widespread use of telemedicine can arise in certain domains regarding data privacy and security. However, telemedicine is an attractive means to improve neonatal outcomes in underserved populations where specialized neonatal facilities are not accessible.
Similarly, another notable technological development is point-of-care ultrasound, which enhances neonatal management and diagnosis. Historically, RDS has been diagnosed by chest X-ray; however, POCUS provides an alternative by providing an instant, cheaper, and safer modality. Facilitating in situ visualization in real time of pulmonary pathology enables physicians to decide upon lung aeration status, detect pneumothorax, among others, among neonates, and guide management decisions without exposing neonates to the use of ionizing radiation (Gjesteby et al., 2022). The advantages of POCUS in neonatal RDS management include that it can quickly evaluate patients, enabling early treatment and diagnosis. It is an economical and portable imaging modality that can be employed in neonatal ICU departments and institutions with fewer resources. Research has confirmed that it is diagnostic in capacity to identify and can be employed by trained individuals with minimal additional training. However, despite its advantages, neonatology has limitations when applying POCUS. Interpretation is operator-dependent in experience and expertise, and mastery has a steep learning curve. It is not an overall pulmonary functional evaluation and should always be employed in concert with clinical evaluation and additional diagnostic methods.
**Conclusion**
Neonatal respiratory distress syndrome exists as a worldwide concern affecting all preterm babies. Early diagnosis, together with effective management, becomes essential since it affects neonatal mortality rates while impacting long-term outcomes. Respiratory disease outcomes show potential for improvement with point-of-care ultrasound technology and telemedicine through specialized care access, diagnosis capabilities, and correct treatment approaches. Through telemedicine technology, parents can access remote medical appointments to receive prompt care while preventing unsafe patient transports. At the same time, point-of-care ultrasound increases the ability to evaluate pulmonary pathologies within the bed where appropriate interventions can be made promptly. The potential drawbacks of these tools do not outweigh the advantages in optimizing neonatal patient outcomes. Medical progress constitutes a crucial element for decreasing the healthcare inequalities experienced by neonates, particularly in neonatology. Healthcare providers should, therefore, adopt these advances to reduce neonatal death rates and deliver better future outcomes for patients who have RDS.
**References**
Chuo, J., Makkar, A., Machut, K., Zenge, J., Jawahar Jagarapu, Abeer Azzuqa, & Savani, R. C. (2022). Telemedicine across the continuum of neonatal-perinatal care.
_Seminars in Fetal and Neonatal Medicine_,
_27_(5), 101398–101398. https://doi.org/10.1016/j.siny.2022.101398
Gjesteby, L. A., Pare, J. R., & Brattain, L. J. (2022). Ultrasound for the Emergency Department and Prehospital Care.
_Engineering and Medicine in Extreme Environments_, 209–234. https://doi.org/10.1007/978-3-030-96921-9_11
Padovani, P., Singh, Y., Pass, R. H., Vasile, C. M., Nield, L. E., & Baruteau, A.-E. (2023). E-Health: A Game Changer in Fetal and Neonatal Cardiology?
_Journal of Clinical Medicine_,
_12_(21), 6865. https://doi.org/10.3390/jcm12216865
Ying, Q., You, X., Luo, F., & Wang, J. (2021). Maternal-Neonatal Serum Albumin Level and Neonatal Respiratory Distress Syndrome in Late-Preterm Infants.
_Frontiers in Pediatrics_,
_9_. https://doi.org/10.3389/fped.2021.666934
**## RoleDevelopmentinFamilyPracticeRDS.ST1.docx**
1
**Role Development in Family Practice: Clinical Integration**
Student’s name
Name of institution
Course name and number
Instructor’s name
Due date
**Role Development in Family Practice: Clinical Integration**
Neonatal illness is an area of continued concern in international pediatrics, with numerous conditions causing rising rates of morbidity and mortality. One of these is neonatal respiratory distress syndrome, an incredibly debilitating illness in preterm neonates due to decreased production of surfactants. This illness results in acute breathing difficulty that, in most instances, warrants immediate specialized attention. RDS has an immense worldwide burden, most especially in developing nations where advanced neonatology facilities are not readily accessible According to World Health Organization reports, preterm birth complications, including RDS, contribute to nearly 35% of global neonatal deaths among the 2.5 million deaths documented in the year 2021. Additionally, the condition RDS occurs in about 1% of all live births, along with affecting 55% of preterm infants born at less than thirty-six weeks. Improved neonatal management and better neonatal diagnosis can significantly reduce neonatal mortality and subsequent complication rates, such as chronic pulmonary disease. The application of evidenced-based technologies in the form of point-of-care ultrasound and telemedicine is an opportunity to diagnose neonates better early in life to direct therapy and provide specialized therapy to remote populations. Applying these technologies is necessary to provide better outcomes for neonates with limited facilities in neonatal intensive units. Healthcare providers can accomplish this by providing timely interventions in neonates with these conditions through these technologies to avoid subsequent complications while improving the family's overall quality of life.
**Neonatal Respiratory Distress Syndrome**
Neonatal respiratory distress syndrome exists as a widespread, serious issue that affects premature infants born earlier than 38 weeks of gestational age. It comes from a deficiency of pulmonary surfactant that produces the condition, which results in high alveolar surface tension and prevents alveolar capacity to exchange gases. An undeveloped amount of surfactant during lung expansion can cause hypoxia, which afterward triggers respiratory failure in newborns. The condition also shows its initial symptoms when the newborn is between zero to a few hours old (Ying et al., 2021). The clinical features include rapid breathing, also known as tachypnea, combined with nasal flaring and grunting, chest retractions, and blue-colored skin, indicating hypoxia. Medical staff primarily make diagnoses of this condition based on clinical evidence alongside blood gas testing and chest X-ray imaging for detecting a distinctive pattern, and continuous positive airway pressure combined with ventilator support receives priority in treatments along with surfactant replacement therapy for promoting lung function.
**Technology and Healthcare**
Technology role has increased neonatal survival rates and reduced related morbidities in diseases like RDS in neonates. Advances in point-of-care ultrasound and telemedicine have provided neonatologists with additional capabilities to treat patients better in remote areas where neonatologists have limited accessibility (Padovani et al., 2023). Telemedicine has introduced remote evaluation, diagnosis, and management of neonates by healthcare providers, irrespective of physical location. It is particularly beneficial in areas where neonatologists and respiratory therapists have limited accessibility. Similarly, POCUS provides in-bed scanning to obtain instant, accurate results regarding pathologies in the lungs in the absence of radiographic exposure. All these tools accelerate early identification and management to achieve better outcomes in neonates and reduce mortality rates.
**Chosen Evidence-Based Technology**
The outcomes of neonatal RDS can be improved significantly by applying telemedicine in resource-limited settings. Neonatologists can support healthcare providers in rural or underserved units through live video conferencing to manage RDS appropriately and promptly. Telemedicine allows remote observation of neonates who have been ventilated to monitor outcomes and prevent unnecessary neonatal transfers while optimizing management programs to prevent complication rates. Telemedicine has been applied in neonatology with notable outcomes. Research has confirmed that telemedicine reduces unnecessary neonatal transfers by allowing remote specialist visits to prevent healthcare expenditures while improving specialist accessibility (Chuo et al., 2022). Telemedicine has been employed to empower parents through improved education to detect early symptoms of respiratory distress and initiate appropriate management in time. However, telemedicine is not free of certain limitations. Low penetration of the internet in specific locations can negate its potential. Additionally, regulatory and legal impediments to the widespread use of telemedicine can arise in certain domains regarding data privacy and security. However, telemedicine is an attractive means to improve neonatal outcomes in underserved populations where specialized neonatal facilities are not accessible.
Similarly, another notable technological development is point-of-care ultrasound, which enhances neonatal management and diagnosis. Historically, RDS has been diagnosed by chest X-ray; however, POCUS provides an alternative by providing an instant, cheaper, and safer modality. Facilitating in situ visualization in real time of pulmonary pathology enables physicians to decide upon lung aeration status, detect pneumothorax, among others, among neonates, and guide management decisions without exposing neonates to the use of ionizing radiation (Gjesteby et al., 2022). The advantages of POCUS in neonatal RDS management include that it can quickly evaluate patients, enabling early treatment and diagnosis. It is an economical and portable imaging modality that can be employed in neonatal ICU departments and institutions with fewer resources. Research has confirmed that it is diagnostic in capacity to identify and can be employed by trained individuals with minimal additional training. However, despite its advantages, neonatology has limitations when applying POCUS. Interpretation is operator-dependent in experience and expertise, and mastery has a steep learning curve. It is not an overall pulmonary functional evaluation and should always be employed in concert with clinical evaluation and additional diagnostic methods.
**Conclusion**
Neonatal respiratory distress syndrome exists as a worldwide concern affecting all preterm babies. Early diagnosis, together with effective management, becomes essential since it affects neonatal mortality rates while impacting long-term outcomes. Respiratory disease outcomes show potential for improvement with point-of-care ultrasound technology and telemedicine through specialized care access, diagnosis capabilities, and correct treatment approaches. Through telemedicine technology, parents can access remote medical appointments to receive prompt care while preventing unsafe patient transports. At the same time, point-of-care ultrasound increases the ability to evaluate pulmonary pathologies within the bed where appropriate interventions can be made promptly. The potential drawbacks of these tools do not outweigh the advantages in optimizing neonatal patient outcomes. Medical progress constitutes a crucial element for decreasing the healthcare inequalities experienced by neonates, particularly in neonatology. Healthcare providers should, therefore, adopt these advances to reduce neonatal death rates and deliver better future outcomes for patients who have RDS.
**References**
Chuo, J., Makkar, A., Machut, K., Zenge, J., Jawahar Jagarapu, Abeer Azzuqa, & Savani, R. C. (2022). Telemedicine across the continuum of neonatal-perinatal care.
_Seminars in Fetal and Neonatal Medicine_,
_27_(5), 101398–101398. https://doi.org/10.1016/j.siny.2022.101398
Gjesteby, L. A., Pare, J. R., & Brattain, L. J. (2022). Ultrasound for the Emergency Department and Prehospital Care.
_Engineering and Medicine in Extreme Environments_, 209–234. https://doi.org/10.1007/978-3-030-96921-9_11
Padovani, P., Singh, Y., Pass, R. H., Vasile, C. M., Nield, L. E., & Baruteau, A.-E. (2023). E-Health: A Game Changer in Fetal and Neonatal Cardiology?
_Journal of Clinical Medicine_,
_12_(21), 6865. https://doi.org/10.3390/jcm12216865
Ying, Q., You, X., Luo, F., & Wang, J. (2021). Maternal-Neonatal Serum Albumin Level and Neonatal Respiratory Distress Syndrome in Late-Preterm Infants.
_Frontiers in Pediatrics_,
_9_. https://doi.org/10.3389/fped.2021.666934
**## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx**
**This is the second part and professor feedback of first part**
**Feedback** Good discussion make sure to use an appropriate tool on week 12 when evaluating the outcomes, specially using telemedicine
**Chosen Evidence-Based Technology Use in Disease or Risk Factor**
-Describe and summarize the evidence-based technology identified that has been shown to improve the condition or Risk Factor for your patient population chosen.
-Compare and contrast the positives and negatives of using this technology use chosen.
**Conclusion**
-Recap points discussed in the paper
-Importance of advancements in technology
**Signature Assignment. Submit the complete paper including the conclusion**
Completion requirements
**Opened:** Monday, March 24, 2025, 11:00 AM
**Due:** Sunday, March 30, 2025, 11:00 PM
Full description of the assignment is included at the end of the syllabus.
In this section the students needs to submit a complete assignment. Which includes: Introduction, Body and Conclusion.
Introduction:
**Introduction:**
Brief overview of the health of the population chosen
-Introduce the global burden of disease OR risk factor chosen
-Importance of improving the condition and its impact on quality of life
**Body of the Paper**
**Global Burden of Disease Condition/Risk Factor**
-Describe the disease OR risk factor chosen
-What signs/symptoms are identified in the patient that can be found?
-How is it diagnosed and treated?
**Technology and Healthcare**
-Describe the paradigm shift in healthcare related to technology
-Elaborate how technology can improve health outcomes in your population
**## RoleDevelopmentinFamilyPracticeRDS.ST1.docx**
1
**Role Development in Family Practice: Clinical Integration**
Student’s name
Name of institution
Course name and number
Instructor’s name
Due date
**Role Development in Family Practice: Clinical Integration**
Neonatal illness is an area of continued concern in international pediatrics, with numerous conditions causing rising rates of morbidity and mortality. One of these is neonatal respiratory distress syndrome, an incredibly debilitating illness in preterm neonates due to decreased production of surfactants. This illness results in acute breathing difficulty that, in most instances, warrants immediate specialized attention. RDS has an immense worldwide burden, most especially in developing nations where advanced neonatology facilities are not readily accessible According to World Health Organization reports, preterm birth complications, including RDS, contribute to nearly 35% of global neonatal deaths among the 2.5 million deaths documented in the year 2021. Additionally, the condition RDS occurs in about 1% of all live births, along with affecting 55% of preterm infants born at less than thirty-six weeks. Improved neonatal management and better neonatal diagnosis can significantly reduce neonatal mortality and subsequent complication rates, such as chronic pulmonary disease. The application of evidenced-based technologies in the form of point-of-care ultrasound and telemedicine is an opportunity to diagnose neonates better early in life to direct therapy and provide specialized therapy to remote populations. Applying these technologies is necessary to provide better outcomes for neonates with limited facilities in neonatal intensive units. Healthcare providers can accomplish this by providing timely interventions in neonates with these conditions through these technologies to avoid subsequent complications while improving the family's overall quality of life.
**Neonatal Respiratory Distress Syndrome**
Neonatal respiratory distress syndrome exists as a widespread, serious issue that affects premature infants born earlier than 38 weeks of gestational age. It comes from a deficiency of pulmonary surfactant that produces the condition, which results in high alveolar surface tension and prevents alveolar capacity to exchange gases. An undeveloped amount of surfactant during lung expansion can cause hypoxia, which afterward triggers respiratory failure in newborns. The condition also shows its initial symptoms when the newborn is between zero to a few hours old (Ying et al., 2021). The clinical features include rapid breathing, also known as tachypnea, combined with nasal flaring and grunting, chest retractions, and blue-colored skin, indicating hypoxia. Medical staff primarily make diagnoses of this condition based on clinical evidence alongside blood gas testing and chest X-ray imaging for detecting a distinctive pattern, and continuous positive airway pressure combined with ventilator support receives priority in treatments along with surfactant replacement therapy for promoting lung function.
**Technology and Healthcare**
Technology role has increased neonatal survival rates and reduced related morbidities in diseases like RDS in neonates. Advances in point-of-care ultrasound and telemedicine have provided neonatologists with additional capabilities to treat patients better in remote areas where neonatologists have limited accessibility (Padovani et al., 2023). Telemedicine has introduced remote evaluation, diagnosis, and management of neonates by healthcare providers, irrespective of physical location. It is particularly beneficial in areas where neonatologists and respiratory therapists have limited accessibility. Similarly, POCUS provides in-bed scanning to obtain instant, accurate results regarding pathologies in the lungs in the absence of radiographic exposure. All these tools accelerate early identification and management to achieve better outcomes in neonates and reduce mortality rates.
**Chosen Evidence-Based Technology**
The outcomes of neonatal RDS can be improved significantly by applying telemedicine in resource-limited settings. Neonatologists can support healthcare providers in rural or underserved units through live video conferencing to manage RDS appropriately and promptly. Telemedicine allows remote observation of neonates who have been ventilated to monitor outcomes and prevent unnecessary neonatal transfers while optimizing management programs to prevent complication rates. Telemedicine has been applied in neonatology with notable outcomes. Research has confirmed that telemedicine reduces unnecessary neonatal transfers by allowing remote specialist visits to prevent healthcare expenditures while improving specialist accessibility (Chuo et al., 2022). Telemedicine has been employed to empower parents through improved education to detect early symptoms of respiratory distress and initiate appropriate management in time. However, telemedicine is not free of certain limitations. Low penetration of the internet in specific locations can negate its potential. Additionally, regulatory and legal impediments to the widespread use of telemedicine can arise in certain domains regarding data privacy and security. However, telemedicine is an attractive means to improve neonatal outcomes in underserved populations where specialized neonatal facilities are not accessible.
Similarly, another notable technological development is point-of-care ultrasound, which enhances neonatal management and diagnosis. Historically, RDS has been diagnosed by chest X-ray; however, POCUS provides an alternative by providing an instant, cheaper, and safer modality. Facilitating in situ visualization in real time of pulmonary pathology enables physicians to decide upon lung aeration status, detect pneumothorax, among others, among neonates, and guide management decisions without exposing neonates to the use of ionizing radiation (Gjesteby et al., 2022). The advantages of POCUS in neonatal RDS management include that it can quickly evaluate patients, enabling early treatment and diagnosis. It is an economical and portable imaging modality that can be employed in neonatal ICU departments and institutions with fewer resources. Research has confirmed that it is diagnostic in capacity to identify and can be employed by trained individuals with minimal additional training. However, despite its advantages, neonatology has limitations when applying POCUS. Interpretation is operator-dependent in experience and expertise, and mastery has a steep learning curve. It is not an overall pulmonary functional evaluation and should always be employed in concert with clinical evaluation and additional diagnostic methods.
**Conclusion**
Neonatal respiratory distress syndrome exists as a worldwide concern affecting all preterm babies. Early diagnosis, together with effective management, becomes essential since it affects neonatal mortality rates while impacting long-term outcomes. Respiratory disease outcomes show potential for improvement with point-of-care ultrasound technology and telemedicine through specialized care access, diagnosis capabilities, and correct treatment approaches. Through telemedicine technology, parents can access remote medical appointments to receive prompt care while preventing unsafe patient transports. At the same time, point-of-care ultrasound increases the ability to evaluate pulmonary pathologies within the bed where appropriate interventions can be made promptly. The potential drawbacks of these tools do not outweigh the advantages in optimizing neonatal patient outcomes. Medical progress constitutes a crucial element for decreasing the healthcare inequalities experienced by neonates, particularly in neonatology. Healthcare providers should, therefore, adopt these advances to reduce neonatal death rates and deliver better future outcomes for patients who have RDS.
**References**
Chuo, J., Makkar, A., Machut, K., Zenge, J., Jawahar Jagarapu, Abeer Azzuqa, & Savani, R. C. (2022). Telemedicine across the continuum of neonatal-perinatal care.
_Seminars in Fetal and Neonatal Medicine_,
_27_(5), 101398–101398. https://doi.org/10.1016/j.siny.2022.101398
Gjesteby, L. A., Pare, J. R., & Brattain, L. J. (2022). Ultrasound for the Emergency Department and Prehospital Care.
_Engineering and Medicine in Extreme Environments_, 209–234. https://doi.org/10.1007/978-3-030-96921-9_11
Padovani, P., Singh, Y., Pass, R. H., Vasile, C. M., Nield, L. E., & Baruteau, A.-E. (2023). E-Health: A Game Changer in Fetal and Neonatal Cardiology?
_Journal of Clinical Medicine_,
_12_(21), 6865. https://doi.org/10.3390/jcm12216865
Ying, Q., You, X., Luo, F., & Wang, J. (2021). Maternal-Neonatal Serum Albumin Level and Neonatal Respiratory Distress Syndrome in Late-Preterm Infants.
_Frontiers in Pediatrics_,
_9_. https://doi.org/10.3389/fped.2021.666934
**## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx**
**This is the second part and professor feedback of first part**
**Feedback** Good discussion make sure to use an appropriate tool on week 12 when evaluating the outcomes, specially using telemedicine
**Chosen Evidence-Based Technology Use in Disease or Risk Factor**
-Describe and summarize the evidence-based technology identified that has been shown to improve the condition or Risk Factor for your patient population chosen.
-Compare and contrast the positives and negatives of using this technology use chosen.
**Conclusion**
-Recap points discussed in the paper
-Importance of advancements in technology
**Signature Assignment. Submit the complete paper including the conclusion**
Completion requirements
**Opened:** Monday, March 24, 2025, 11:00 AM
**Due:** Sunday, March 30, 2025, 11:00 PM
Full description of the assignment is included at the end of the syllabus.
In this section the students needs to submit a complete assignment. Which includes: Introduction, Body and Conclusion.
Introduction:
**Introduction:**
Brief overview of the health of the population chosen
-Introduce the global burden of disease OR risk factor chosen
-Importance of improving the condition and its impact on quality of life
**Body of the Paper**
**Global Burden of Disease Condition/Risk Factor**
-Describe the disease OR risk factor chosen
-What signs/symptoms are identified in the patient that can be found?
-How is it diagnosed and treated?
**Technology and Healthcare**
-Describe the paradigm shift in healthcare related to technology
-Elaborate how technology can improve health outcomes in your population
**## RoleDevelopmentinFamilyPracticeRDS.ST1.docx**
1
**Role Development in Family Practice: Clinical Integration**
Student’s name
Name of institution
Course name and number
Instructor’s name
Due date
**Role Development in Family Practice: Clinical Integration**
Neonatal illness is an area of continued concern in international pediatrics, with numerous conditions causing rising rates of morbidity and mortality. One of these is neonatal respiratory distress syndrome, an incredibly debilitating illness in preterm neonates due to decreased production of surfactants. This illness results in acute breathing difficulty that, in most instances, warrants immediate specialized attention. RDS has an immense worldwide burden, most especially in developing nations where advanced neonatology facilities are not readily accessible According to World Health Organization reports, preterm birth complications, including RDS, contribute to nearly 35% of global neonatal deaths among the 2.5 million deaths documented in the year 2021. Additionally, the condition RDS occurs in about 1% of all live births, along with affecting 55% of preterm infants born at less than thirty-six weeks. Improved neonatal management and better neonatal diagnosis can significantly reduce neonatal mortality and subsequent complication rates, such as chronic pulmonary disease. The application of evidenced-based technologies in the form of point-of-care ultrasound and telemedicine is an opportunity to diagnose neonates better early in life to direct therapy and provide specialized therapy to remote populations. Applying these technologies is necessary to provide better outcomes for neonates with limited facilities in neonatal intensive units. Healthcare providers can accomplish this by providing timely interventions in neonates with these conditions through these technologies to avoid subsequent complications while improving the family's overall quality of life.
**Neonatal Respiratory Distress Syndrome**
Neonatal respiratory distress syndrome exists as a widespread, serious issue that affects premature infants born earlier than 38 weeks of gestational age. It comes from a deficiency of pulmonary surfactant that produces the condition, which results in high alveolar surface tension and prevents alveolar capacity to exchange gases. An undeveloped amount of surfactant during lung expansion can cause hypoxia, which afterward triggers respiratory failure in newborns. The condition also shows its initial symptoms when the newborn is between zero to a few hours old (Ying et al., 2021). The clinical features include rapid breathing, also known as tachypnea, combined with nasal flaring and grunting, chest retractions, and blue-colored skin, indicating hypoxia. Medical staff primarily make diagnoses of this condition based on clinical evidence alongside blood gas testing and chest X-ray imaging for detecting a distinctive pattern, and continuous positive airway pressure combined with ventilator support receives priority in treatments along with surfactant replacement therapy for promoting lung function.
**Technology and Healthcare**
Technology role has increased neonatal survival rates and reduced related morbidities in diseases like RDS in neonates. Advances in point-of-care ultrasound and telemedicine have provided neonatologists with additional capabilities to treat patients better in remote areas where neonatologists have limited accessibility (Padovani et al., 2023). Telemedicine has introduced remote evaluation, diagnosis, and management of neonates by healthcare providers, irrespective of physical location. It is particularly beneficial in areas where neonatologists and respiratory therapists have limited accessibility. Similarly, POCUS provides in-bed scanning to obtain instant, accurate results regarding pathologies in the lungs in the absence of radiographic exposure. All these tools accelerate early identification and management to achieve better outcomes in neonates and reduce mortality rates.
**Chosen Evidence-Based Technology**
The outcomes of neonatal RDS can be improved significantly by applying telemedicine in resource-limited settings. Neonatologists can support healthcare providers in rural or underserved units through live video conferencing to manage RDS appropriately and promptly. Telemedicine allows remote observation of neonates who have been ventilated to monitor outcomes and prevent unnecessary neonatal transfers while optimizing management programs to prevent complication rates. Telemedicine has been applied in neonatology with notable outcomes. Research has confirmed that telemedicine reduces unnecessary neonatal transfers by allowing remote specialist visits to prevent healthcare expenditures while improving specialist accessibility (Chuo et al., 2022). Telemedicine has been employed to empower parents through improved education to detect early symptoms of respiratory distress and initiate appropriate management in time. However, telemedicine is not free of certain limitations. Low penetration of the internet in specific locations can negate its potential. Additionally, regulatory and legal impediments to the widespread use of telemedicine can arise in certain domains regarding data privacy and security. However, telemedicine is an attractive means to improve neonatal outcomes in underserved populations where specialized neonatal facilities are not accessible.
Similarly, another notable technological development is point-of-care ultrasound, which enhances neonatal management and diagnosis. Historically, RDS has been diagnosed by chest X-ray; however, POCUS provides an alternative by providing an instant, cheaper, and safer modality. Facilitating in situ visualization in real time of pulmonary pathology enables physicians to decide upon lung aeration status, detect pneumothorax, among others, among neonates, and guide management decisions without exposing neonates to the use of ionizing radiation (Gjesteby et al., 2022). The advantages of POCUS in neonatal RDS management include that it can quickly evaluate patients, enabling early treatment and diagnosis. It is an economical and portable imaging modality that can be employed in neonatal ICU departments and institutions with fewer resources. Research has confirmed that it is diagnostic in capacity to identify and can be employed by trained individuals with minimal additional training. However, despite its advantages, neonatology has limitations when applying POCUS. Interpretation is operator-dependent in experience and expertise, and mastery has a steep learning curve. It is not an overall pulmonary functional evaluation and should always be employed in concert with clinical evaluation and additional diagnostic methods.
**Conclusion**
Neonatal respiratory distress syndrome exists as a worldwide concern affecting all preterm babies. Early diagnosis, together with effective management, becomes essential since it affects neonatal mortality rates while impacting long-term outcomes. Respiratory disease outcomes show potential for improvement with point-of-care ultrasound technology and telemedicine through specialized care access, diagnosis capabilities, and correct treatment approaches. Through telemedicine technology, parents can access remote medical appointments to receive prompt care while preventing unsafe patient transports. At the same time, point-of-care ultrasound increases the ability to evaluate pulmonary pathologies within the bed where appropriate interventions can be made promptly. The potential drawbacks of these tools do not outweigh the advantages in optimizing neonatal patient outcomes. Medical progress constitutes a crucial element for decreasing the healthcare inequalities experienced by neonates, particularly in neonatology. Healthcare providers should, therefore, adopt these advances to reduce neonatal death rates and deliver better future outcomes for patients who have RDS.
**References**
Chuo, J., Makkar, A., Machut, K., Zenge, J., Jawahar Jagarapu, Abeer Azzuqa, & Savani, R. C. (2022). Telemedicine across the continuum of neonatal-perinatal care.
_Seminars in Fetal and Neonatal Medicine_,
_27_(5), 101398–101398. https://doi.org/10.1016/j.siny.2022.101398
Gjesteby, L. A., Pare, J. R., & Brattain, L. J. (2022). Ultrasound for the Emergency Department and Prehospital Care.
_Engineering and Medicine in Extreme Environments_, 209–234. https://doi.org/10.1007/978-3-030-96921-9_11
Padovani, P., Singh, Y., Pass, R. H., Vasile, C. M., Nield, L. E., & Baruteau, A.-E. (2023). E-Health: A Game Changer in Fetal and Neonatal Cardiology?
_Journal of Clinical Medicine_,
_12_(21), 6865. https://doi.org/10.3390/jcm12216865
Ying, Q., You, X., Luo, F., & Wang, J. (2021). Maternal-Neonatal Serum Albumin Level and Neonatal Respiratory Distress Syndrome in Late-Preterm Infants.
_Frontiers in Pediatrics_,
_9_. https://doi.org/10.3389/fped.2021.666934